“Stability Indicating RP-UPLC Method Development & Validation for Quantitation of Doravirine in Tablet Formulation ”. (2023) 2023. Journal of Pharmaceutical Negative Results 13 (4): 1776-82. https://doi.org/10.47750/pnr.2022.13.04.243.